Research advances in renal replacement therapy for hepatorenal syndrome / 临床肝胆病杂志
Journal of Clinical Hepatology
;
(12): 605-608, 2016.
Artículo
en Chino
| WPRIM
| ID: wpr-778591
ABSTRACT
Hepatorenal syndrome (HRS) is a serious complication of the end-stage liver disease. The overall treatment outcome of HRS is not satisfactory, with a short survival time and a poor prognosis. Currently, renal replacement therapy is one of the main non-transplantation therapeutic methods, but its clinical effect remains controversial. This review summarizes the research on HRS and advances in the clinical effect of renal replacement therapy for HRS, and points out that renal replacement therapy is not suitable as the conventional therapy for HRS, but it can be applied as the pre-transplantation transitional treatment for patients with a plan for liver transplantation, as well as the short-term treatment for non-transplantation patients who do not respond to vasoconstrictors.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of Clinical Hepatology
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS